Medicxi Growth I LP

CIK 1690310 · last filed 2021-12-06

Medicxi Growth I LP is a corporate insider who has filed 1 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing shows the insider bought $1.8M of CNTA on Dec 6, 2021. Across all open-market trades the lifetime net is +$1.8M, making them a net buyer over the disclosed history. The firm reports its address in St Helier, Y9. 10 SEC filings were submitted jointly with Medicxi Growth Co-Invest I LP.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

Companies

Total Filings

Lifetime Open-Market Net

$1.76M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

Filer Profile

Reported Address

C/O ELIAN FUND SERVICES (JERSEY) LIMITED
44 ESPLANADE
ST HELIER, Y9 JE4 9WG

Phone

44 (0)1534 504343

State of Incorporation

Jersey

Related Filers

Medicxi Growth Co-Invest I LP — 10 joint filings, latest 2026-06-24

Medicxi Growth I GP Ltd — 10 joint filings, latest 2026-06-24

Medicxi Ventures I GP Ltd — 3 joint filings, latest 2026-06-24

Medicxi Secondary I GP Ltd. — 2 joint filings, latest 2026-06-24

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
Centessa Pharmaceuticals plc (CNTA) Delisted	10%+ Owner	93,526	$40.50	$3.79M	$1.76M	1	2021-12-06

Recent Filings

1 filing

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2021-12-06	Centessa Pharmaceuticals plc (CNTA) Delisted	Buy (P)	+137,304	$1.76M	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.